Company

Agenus

Private

Agenus is a privately held company. Leadership tracked by CEOInsider includes Garo H. Armen (CEO).

Leadership

Current

In the news

Garo H. Armen
Jul 26 · Agenus
AGEN|Agenus Inc|Price:7.500|Chg%:-0.410
via TradingKey ↗
Garo H. Armen
Jul 14 · Agenus
Agenus Discontinues Phase 3 BATTMAN Trial in Metastatic MSS Colorectal Cancer
via CancerNetwork ↗
Garo H. Armen
Jun 30 · Agenus
Agenus (AGEN) director Armen takes June 2026 salary in 5,364 company shares
via Stock Titan ↗
Garo H. Armen
May 11 · Agenus
Agenus Reports First Quarter 2026 Financial Results and Highlights BOT+BAL Execution Across Global Access and Phase 3 Development
via Business Wire ↗
Garo H. Armen
Apr 21 · Agenus
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
via Business Wire ↗
Garo H. Armen
Feb 13 · Agenus
Response to the Misleading Open Letter by “Diaspora Leaders”: Statement by Dr. Garo Armen, Founder of the Children of Armenia Fund (COAF)
via MassisPost ↗
Garo H. Armen
Jun 10 · Agenus
Agenus and GSK tout positive Phase 3 data for RSV vaccine
via drugdiscoverytrends.com ↗
Garo H. Armen
May 2 · Agenus
Garo Armen - Children of Armenia Fund (COAF)
via ABILITY Magazine ↗